RIV Capital Inc. (RIV.CN) Research

RIV Capital Inc., formerly known as Canopy Rivers Inc., operates as a venture capital firm with a versatile investment approach. While open to opportunities across all company stages, from initial seed funding through commercialization, its primary focus is on Series A through C financing rounds. The firm's strategic interest is firmly rooted in the burgeoning cannabis sector, actively seeking out promising marijuana-related businesses and adjacent industries. Its comprehensive investment scope encompasses a wide array of areas: Agriculture and food sciences: Spanning plant, soil, food, animal, and environmental science. Production: Including diverse cultivation methods such as indoor, greenhouse, outdoor, and nursery, alongside fermentation. Processing: Involving harvesting, extraction, purification, packaging, food and beverage processing, and laboratory testing services. Pharmaceuticals and biotechnology: Covering drug discovery and development, various delivery methods (e.g., pills, soft gels, tinctures), biosynthetic derived cannabinoids, medical devices (e.g., inhalers), and lab equipment. Technology and consumer goods: Such as software and data, specialized hardware, consumer products and accessories (e.g., edibles, beverages, inhalables, cosmetics, cannabis consumption tools), and wellness products. Market access: Including retail and distribution channels (licensed brick-and-mortar stores, pharmacies, online marketplaces, delivery services), and media and content creation. Furthermore, specific product categories of interest include beverages, capsules, concentrates, edibles, dry flower/pre-rolls, vaporizers and associated hardware, pet products, and topicals. RIV Capital actively pursues investment prospects on a global scale. While check sizes have historically ranged from CA$1 million (approximately $0.71 million USD) to CA$40 million (around $28.45 million USD), the firm typically invests between CA$5 million (roughly $3.6 million USD) and CA$10 million (approximately $7.1 million USD). The firm generally seeks to acquire minority ownership stakes and employs a flexible array of investment instruments, including debt financing, preferred and common equity, and production-linked royalties. RIV Capital Inc. was established in 2017 and is headquartered in Toronto, Canada.

Market snapshot

Symbol
RIV.CN
Price
$0.10
Day change
-4.76%
Market cap
$9.7M
P/E ratio
-0.11x
52-week range
0.0-0.23
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aleafia Health Inc. (AH.TO)
  • Chalice Brands Ltd. (CHAL.CN)
  • CloudMD Software & Services Inc. (DOC.V)
  • EXMceuticals Inc. (EXM.CN)
  • Fire & Flower Holdings Corp. (FAF.TO)
  • IMV Inc. (IMV.TO)
  • Khiron Life Sciences Corp. (KHRN.V)
  • Marvell Technology, Inc. (MRV.TO)

Open RIV Capital Inc. (RIV.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.